Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Nutritopper Biotechnology is a Chinese life sciences company specializing in the research, development, and commercialization of high-purity nutritional ingredients and bioactive plant extracts. The company's product portfolio features key compounds such as L-carnosine, reduced glutathione, and alpha-arbutin, which serve as critical raw materials for the pharmaceutical, nutraceutical, and personal care industries. Nutritopper employs advanced extraction and enzymatic synthesis technologies to produce standardized ingredients that meet international quality benchmarks. Headquartered in Changsha, the firm operates a robust export business, supplying global manufacturers with antioxidants and anti-aging agents. Their expertise extends to custom synthesis and the development of specialized biochemical reagents for laboratory research. By integrating traditional extraction methods with modern biotechnology, Nutritopper supports the formulation of functional health products and dermatological treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Nutritopper Biotechnology.